NASDAQ:SWKH

SWK - SWKH Stock Forecast, Price & News

$17.00

-0.03 (-0.18%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $16.80
▼
$17.16
50-Day Range: $16.25
▼
$18.73
52-Week Range: $16.06
▼
$20.19

Volume: 8,822 shs
Average Volume: 14,246 shs
Market Capitalization: $218.11 million

P/E Ratio: 17.53
Dividend Yield: N/A
Price Target: $31.00

SWK MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 82.4% Upside
$31.00 Price Target
Short Interest: Healthy
0.39% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.64 out of 5 stars

Finance Sector

346th out of 923 stocks

Miscellaneous Business Credit Industry

2nd out of 2 stocks

3.5

Analyst's Opinion

Consensus Rating
SWK has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $31.00, SWK has a forecasted upside of 82.4% from its current price of $17.00.
Amount of Analyst Coverage
SWK has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
0.39% of the float of SWK has been sold short.
Short Interest Ratio / Days to Cover
SWK has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in SWK has recently decreased by 2.78%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
SWK does not currently pay a dividend.
Dividend Growth
SWK does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SWKH.

3.8

News and Social Media Coverage

News Sentiment
SWK has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Finance companies.
News Coverage This Week
MarketBeat has tracked 1 news article for SWK this week, compared to 0 articles on an average week.
Search Interest
1 people have searched for SWKH on MarketBeat in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SWK insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.70% of the stock of SWK is held by insiders.
Percentage Held by Institutions
97.00% of the stock of SWK is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of SWK is 17.53, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 122.16.
Price to Earnings Ratio vs. Sector
The P/E ratio of SWK is 17.53, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 158.02.
Price to Book Value per Share Ratio
SWK has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About SWK (NASDAQ:SWKH) Stock

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endocrine disease. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

Receive SWKH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SWK and its competitors with MarketBeat's FREE daily newsletter.

SWKH Stock News Headlines

September 12, 2022 | finance.yahoo.com

Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides

September 2, 2022 | nasdaq.com

SWK Holdings Says Jody Staggs To Be Interim CEO As Chairman & CEO Winston Black Quits

September 1, 2022 | marketwatch.com

SWK Chairman, CEO Winston Black to Leave >SWKH

August 10, 2022 | finance.yahoo.com

SWK Holdings Corporation Announces Financial Results for Second Quarter 2022

August 9, 2022 | finance.yahoo.com

SWK Holdings Corporation to Report Second Quarter 2022 Financial Results

August 3, 2022 | finance.yahoo.com

Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing

July 14, 2022 | finance.yahoo.com

Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo

July 13, 2022 | finance.yahoo.com

SWK Holdings Corporation Marks 10th Anniversary, Celebrating Growth and Progress

June 27, 2022 | seekingalpha.com

SWK Holdings added to Russell 3000, Russell 2000 and Russell microcap Indexes

May 19, 2022 | seekingalpha.com

SWK Holdings files for $200M mixed shelf offering

May 19, 2022 | finance.yahoo.com

SWK Holdings Corporation Announces Filing of Form S-3 Shelf Registration Statement

May 11, 2022 | investing.com

SWK Holdings Tops Q1 EPS by 2c

May 11, 2022 | finance.yahoo.com

SWK Holdings Corporation Announces Financial Results for First Quarter 2022

May 10, 2022 | finance.yahoo.com

SWK Holdings Corporation to Report First Quarter 2022 Financial Results

May 4, 2022 | finance.yahoo.com

Enteris BioPharma to Exhibit at CPhI North America 2022

April 12, 2022 | finance.yahoo.com

Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference

April 4, 2022 | finance.yahoo.com

Enteris BioPharma Highlighted as Game Changer in Drug Development & Delivery Special Feature on Innovative Technologies for Improving Drug Solubility and Bioavailability

March 28, 2022 | finance.yahoo.com

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2021

March 25, 2022 | finance.yahoo.com

AOTI Secures Major Expansion Funding from Leading Healthcare Financier

March 7, 2022 | seekingalpha.com

Enteris highlights practices for content uniformity in solid oral dosage manufacturing

March 7, 2022 | finance.yahoo.com

Enteris BioPharma Publishes White Paper on Best Practices for Ensuring Content Uniformity in Solid Oral Dosage Manufacturing with HPAPI

March 2, 2022 | finance.yahoo.com

Enteris BioPharma to Participate in DCAT® Week 2022

February 17, 2022 | finance.yahoo.com

SWK Holdings Announces Reconstitution of Board of Directors with New Appointments

February 15, 2022 | finance.yahoo.com

Enteris BioPharma Highlights Progress in Oral Feasibility Program

January 25, 2022 | nasdaq.com

SWK Holdings Corporation Common Stock (SWKH)

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SWKH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SWK and its competitors with MarketBeat's FREE daily newsletter.

SWKH Company Calendar

Last Earnings: 11/12/2021
Today: 10/02/2022
Next Earnings (Estimated): 11/11/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Miscellaneous business credit
Sub-Industry: N/A
Sector: Finance
Current Symbol: NASDAQ:SWKH
CUSIP: N/A
CIK: 1089907
Web: www.swkhold.com
Phone: (972) 687-7250
Fax: 972-687-7255
Employees: 35
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $31.00
High Stock Price Forecast: $36.00
Low Stock Price Forecast: $26.00
Forecasted Upside/Downside: +82.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.97
Trailing P/E Ratio: 17.53
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $25.93 million
Net Margins: 29.62%
Pretax Margin: 38.74%
Return on Equity: 8.21%
Return on Assets: 7.78%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 21.20
Quick Ratio: 21.20

Sales & Book Value

Annual Sales: $56.15 million
Price / Sales: 3.88
Cash Flow: $3.01 per share
Price / Cash Flow: 5.64
Book Value: $20.86 per share
Price / Book: 0.81

Miscellaneous

Outstanding Shares: 12,830,000
Free Float: 12,611,000
Market Cap: $218.11 million
Optionable: Not Optionable
Beta: 0.21

Key Executives

Mr. Winston Lee Black III (Age 47)
CEO & Chairman
Comp: $1.57M

Mr. Charles M. Jacobson (Age 50)
Chief Financial Officer
Comp: $140k

Ms. Yvette Heinrichson
Chief Accounting Officer

David R. Earhart
Gen. Counsel & Sec.

Mr. Jody Staggs
Managing Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SWKH Stock - Frequently Asked Questions

Should I buy or sell SWK stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SWK in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SWKH shares.
View SWKH analyst ratings or view top-rated stocks.
What is SWK's stock price forecast for 2022?: 2 Wall Street analysts have issued 1 year price objectives for SWK's shares. Their SWKH share price forecasts range from $26.00 to $36.00. On average, they predict the company's stock price to reach $31.00 in the next twelve months. This suggests a possible upside of 82.4% from the stock's current price.
View analysts price targets for SWKH or view top-rated stocks among Wall Street analysts.
How have SWKH shares performed in 2022?: SWK's stock was trading at $19.63 at the start of the year. Since then, SWKH shares have decreased by 13.4% and is now trading at $17.00.
View the best growth stocks for 2022 here.
When is SWK's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, November 11th 2022.
View our SWKH earnings forecast.

How were SWK's earnings last quarter?: SWK Holdings Co. (NASDAQ:SWKH) issued its quarterly earnings data on Friday, November, 12th. The company reported $0.33 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by $0.14. The firm had revenue of $9.56 million for the quarter. SWK had a trailing twelve-month return on equity of 8.21% and a net margin of 29.62%.
What is SWK's stock symbol?: SWK trades on the NASDAQ under the ticker symbol "SWKH."
How do I buy shares of SWK?: Shares of SWKH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is SWK's stock price today?: One share of SWKH stock can currently be purchased for approximately $17.00.
How much money does SWK make?: SWK (NASDAQ:SWKH) has a market capitalization of $218.11 million and generates $56.15 million in revenue each year. The company earns $25.93 million in net income (profit) each year or $0.97 on an earnings per share basis.
How can I contact SWK?: SWK's mailing address is 14755 PRESTON ROAD SUITE 105, DALLAS TX, 75254. The official website for the company is www.swkhold.com. The company can be reached via phone at (972) 687-7250, via email at investorrelations@swkhold.com, or via fax at 972-687-7255.

This page (NASDAQ:SWKH) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SWK - SWKH Stock Forecast, Price & News

SWK MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month